Carboplatin is primarily used in chemotherapy to treat various types of cancer. It is especially effective in treating ovarian cancer and is often used when initial treatments have not been successful. It is also used in the treatment of lung cancer, head and neck cancers, and certain types of brain tumors. The drug works by interfering with the DNA in cancer cells, preventing them from dividing and growing. Because it is less toxic to the kidneys than similar drugs like cisplatin, it is often preferred for patients who may be more vulnerable to side effects. Carboplatin is usually administered intravenously in a hospital or clinic setting, typically in cycles that allow the body time to recover between doses. It is often combined with other chemotherapy agents to enhance its effectiveness. Its use is carefully monitored due to potential side effects such as bone marrow suppression, which can lead to reduced blood cell counts.